- Home
- ANEB vs INCR Comparison
ANEB vs INCR Comparison
Compare ANEB & INCR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ANEB
- INCR
- Stock Information
- Founded
- ANEB 2020
- INCR 1994
- Country
- ANEB United States
- INCR Israel
- Employees
- ANEB N/A
- INCR N/A
- Industry
- ANEB Biotechnology: Pharmaceutical Preparations
- INCR Biotechnology: Pharmaceutical Preparations
- Sector
- ANEB Health Care
- INCR Health Care
- Exchange
- ANEB Nasdaq
- INCR Nasdaq
- Market Cap
- ANEB 98.6M
- INCR 83.5M
- IPO Year
- ANEB 2021
- INCR N/A
- Fundamental
- Price
- ANEB $2.28
- INCR $1.61
- Analyst Decision
- ANEB Buy
- INCR
- Analyst Count
- ANEB 2
- INCR 0
- Target Price
- ANEB $8.00
- INCR N/A
- AVG Volume (30 Days)
- ANEB 124.0K
- INCR 131.4K
- Earning Date
- ANEB 11-12-2025
- INCR 08-28-2025
- Dividend Yield
- ANEB N/A
- INCR N/A
- EPS Growth
- ANEB N/A
- INCR N/A
- EPS
- ANEB N/A
- INCR N/A
- Revenue
- ANEB N/A
- INCR $65,575,323.00
- Revenue This Year
- ANEB N/A
- INCR $69.54
- Revenue Next Year
- ANEB N/A
- INCR $41.75
- P/E Ratio
- ANEB N/A
- INCR N/A
- Revenue Growth
- ANEB N/A
- INCR N/A
- 52 Week Low
- ANEB $0.80
- INCR $1.17
- 52 Week High
- ANEB $3.42
- INCR $1.87
- Technical
- Relative Strength Index (RSI)
- ANEB 42.33
- INCR 57.01
- Support Level
- ANEB $2.34
- INCR $1.40
- Resistance Level
- ANEB $2.47
- INCR $1.65
- Average True Range (ATR)
- ANEB 0.12
- INCR 0.06
- MACD
- ANEB -0.02
- INCR 0.01
- Stochastic Oscillator
- ANEB 13.49
- INCR 81.48
About ANEB Anebulo Pharmaceuticals Inc.
Anebulo Pharmaceuticals Inc is a clinical-stage biotechnology company focused on developing treatments for cannabinoid overdose and substance addiction. Its principal product candidate, ANEB-001 (Selonabant), is designed to rapidly counteract the negative effects of cannabis toxicity, including unintentional cannabis poisoning and acute cannabinoid intoxication. The company is focusing on addressing the unmet medical needs in the treatment of cannabinoid toxicity through various therapies.
About INCR Intercure Ltd.
Intercure Ltd is engaged in the research, cultivation, production, and distribution of pharma-grade cannabis-based products. Its products are available in dried inflorescences or liquid oil form, and are marketed through various brands, including Pharmo Cann, Humboldt, Indoor, Space Labs, Canndoc Utopia, Binske, Canndoc Stars, and others. The company has two operating segments, namely Investments in portfolio companies in the biomed sector and Investments in the medical cannabis sector. A majority of its revenue is generated from the Cannabis segment.